NOVARTIS
Updates & Highlights
Novartis reports positive results from Phase III ALIGN trial for IgAN
Novartis reports positive results from Phase III ALIGN trial for IgAN
Yahoo · 1 day ago
EULAR: Novartis Closes In On Final Approval For Cosentyx
EULAR: Novartis Closes In On Final Approval For Cosentyx
Citeline News & Insights · 1 day ago
Novartis AG Stock (NVS) Closed Up by 3.12% on Jun 4: A Full Analysis
Novartis AG Stock (NVS) Closed Up by 3.12% on Jun 4: A Full Analysis
TradingKey · 2 days ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
401(k) Match
Retirement savings
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Novartis?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentNovartis reports positive results from Phase III ALIGN trial for IgAN
Novartis reports positive results from Phase III ALIGN trial for IgAN
Yahoo · 1 day ago
EULAR: Novartis Closes In On Final Approval For Cosentyx
EULAR: Novartis Closes In On Final Approval For Cosentyx
Citeline News & Insights · 1 day ago
Novartis AG Stock (NVS) Closed Up by 3.12% on Jun 4: A Full Analysis
Novartis AG Stock (NVS) Closed Up by 3.12% on Jun 4: A Full Analysis
TradingKey · 2 days ago
Novartis IgAN data in The Lancet show clinically meaningful
Novartis IgAN data in The Lancet show clinically meaningful
GlobeNewswire · 2 days ago
Novartis Cosentyx® Pmr Data In New England Journal Of Medicine Showed Sustained Remission Versus Placebo In Twice As Many Patients
Novartis Cosentyx® Pmr Data In New England Journal Of Medicine Showed Sustained Remission Versus Placebo In Twice As Many Patients
TradingView · 3 days ago
Male contraception startup closes $92.5M Series B; Novartis bets on actinium in Phase 3
Male contraception startup closes $92.5M Series B; Novartis bets on actinium in Phase 3
Endpoints News · 4 days ago
ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture
ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture
Pharmaceutical Technology · 4 days ago
ASCO26: Celcuity's drug halves risk of disease progression, death versus Novartis' Piqray in PIK3CA-mutant breast cancer
ASCO26: Celcuity's drug halves risk of disease progression, death versus Novartis' Piqray in PIK3CA-mutant breast cancer
FirstWord Pharma · 4 days ago
Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled
Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled
TradingKey · 5 days ago
Novartis announces results on rPFS improvements across subgroups with Pluvicto
Novartis announces results on rPFS improvements across subgroups with Pluvicto
Yahoo Finance · 5 days ago
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
Yahoo Finance UK · 5 days ago
Novartis data at EULAR 2026 demonstrates momentum for broad
Novartis data at EULAR 2026 demonstrates momentum for broad
GlobeNewswire · 5 days ago
Experimental Novartis radiopharma drug shows promise in early study
Experimental Novartis radiopharma drug shows promise in early study
Reuters · 6 days ago
Final Frontier Releases Animated Film "The Guide" for Novartis Directed by Andrea Devia-Nuño
Final Frontier Releases Animated Film "The Guide" for Novartis Directed by Andrea Devia-Nuño
Roastbrief US · 8 days ago
Novartis ‘always looking’ for further ways to shuttle drugs to brain despite run of recent deals
Novartis ‘always looking’ for further ways to shuttle drugs to brain despite run of recent deals
Fierce Biotech · 9 days ago
Novartis' groundbreaking, business updates: 5 trending stories from around Denton in May
Novartis' groundbreaking, business updates: 5 trending stories from around Denton in May
Community Impact | News · 9 days ago
Novartis buys Avidity Biosciences as part of broader spending spree
Novartis buys Avidity Biosciences as part of broader spending spree
SWI swissinfo.ch · 10 days ago
Novartis Breaks Ground On Denton, Texas Radioligand Therapy Site
Novartis Breaks Ground On Denton, Texas Radioligand Therapy Site
Construction Equipment Guide · 11 days ago
Novartis cutting more jobs at East Hanover HQ (updated)
Novartis cutting more jobs at East Hanover HQ (updated)
NJBIZ · 11 days ago
Barclays, JPMorgan Chase, Meta and Novartis to lay off hundreds in NJ
Barclays, JPMorgan Chase, Meta and Novartis to lay off hundreds in NJ
Bergen Record · 11 days ago